[Long-term treatment of arthrosis using Arumalon].
Cartilage and bone marrow extracts have been used to enhance cartilage mucopolysaccharide levels. The value of this form of treatment was appraised in 250 groups of 250 patients with well established arthrosis. Comparison was made between standard management with anti-inflammatory drugs, analgesics, anti-rheumatic compounds, physiotherapy and heat treatment, and management with the addition of cartilage and bone marrow extracts (Arumalon) over a period of 5 yr. Patients who received Arumalon had a lower frequency of painful exacerbations, a lower and more delayed frequency of functional incapacity, and a slower and less striking radiological progression. These results corroborate experimental and clinical data in the literature. They were particularly marked in 50 cases of gonarthrosis.
D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001853:Bone Marrow; D002356:Cartilage; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D010007:Osteochondritis / Q000188:drug therapy*; D013997:Time Factors; D014020:Tissue Extracts / Q000627:therapeutic use*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D014020:Tissue Extracts
Trattamento a lungo termine dell'artrosi con "Arumalon"